Product Images Losartan Potassium

This appears to be a graph or chart depicting the comparison between two medications, Atenolol and Losartan, regarding the percentage of patients with the primary endpoint. The adjusted risk reduction is shown to be 13%, with a p-value of 0.021. The x-axis shows study months from 0 to 66. No further information is available from this text.*

The text provides information on the comparison between Atenolol and Losartan in terms of the percentage of patients with fatal/non-fatal stroke. The adjusted risk reduction is mentioned as 25% with a p-value of 0.001. The numbers from 6 to 66 are given, likely representing study months.*

This appears to be a table showing the results of a medical study comparing the effectiveness of Losartan and Atenolol in reducing the risk of stroke in patients with different risk factors such as age, gender, history of CVD and diabetes. The table displays the number and percentage of patients who experienced a stroke, as well as the Hazard Ratio for each group. However, there is not enough information to provide a more in-depth description or analysis of the study.*

This data is not sufficient to generate a useful description as it consists only of numerical values and no context or information about what these values represent.*

This appears to be a product label for a bottle of 30 tablets containing 50mg of potassium. The product is identified as "ei53-0" and the brand name "TolarTaN" is also visible. The label also contains the numbers "1mc" and "zotpe" which may be batch or lot numbers. There is also a section that reads "Stone AT 7 occnees" and "BRTeE oyt" which are not clear and may not be relevant to the product.*